Accessibility Menu
 
Khiron Life Sciences logo

Khiron Life Sciences

(OTC) KHRNF

Current Price$0.00
Market CapN/A
Since IPO (2018)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Khiron Life Sciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$16.14M

Net Income (TTM)

$30.66M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

670.09 (High)

Price

$0.00

Volume

4,650

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

KHRNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Khiron Life Sciences

Industry

Pharmaceuticals

Employees

310

CEO

Álvaro F. Torres, MBA

Headquarters

Vancouver, BC V6C 2B5, CA

KHRNF Financials

Key Financial Metrics (TTM)

Gross Margin

22%

Operating Margin

-2%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

-65%

Return on Assets

-78%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

4.65K

Short Interest

0.00%

Avg. Volume

1.60K

Financials (TTM)

Gross Profit

$6.37M

Operating Income

$19.79M

EBITDA

$32.03M

Operating Cash Flow

$20.40M

Capital Expenditure

$1.74M

Free Cash Flow

$22.14M

Cash & ST Invst.

$8.92M

Total Debt

$2.23M

Khiron Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$3.38M

-3.8%

Gross Profit

$1.65M

-8.8%

Gross Margin

48.83%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

310

N/A

Net Income

$3.58M

-7.2%

EBITDA

$2.89M

+32.3%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Net Cash

$626.00K

-104.6%

Accounts Receivable

$4.38M

+7.3%

Inventory

$9.81M

-1.3%

Long Term Debt

$1.34M

N/A

Short Term Debt

$1.23M

+290.3%

Return on Assets

-78.37%

N/A

Return on Invested Capital

-64.62%

N/A

Free Cash Flow

$5.92M

-16.8%

Operating Cash Flow

$5.04M

-3.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KAYSKaya Holdings, Inc.
$0.03+1.27%
EVIOEVIO, Inc.
$0.00+0.00%
ANTCFAion Therapeutic Inc.
$0.00+0.00%
SHMNSOHM, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%

Questions About KHRNF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.